Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, Par Value $0.001 Per Share
-
Shares outstanding
-
47M
-
Number of holders
-
72
-
Total shares
-
12M
-
Shares change
-
-2.38M
-
Total reported value, excl. options
-
$298M
-
Value change
-
-$58.9M
-
Number of buys
-
30
-
Number of sells
-
-30
-
Price
-
$24.85
Significant Holders of Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) as of Q1 2025
78 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share as of Q1 2025.
Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12M shares
of 47M outstanding shares and own 25.53% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (7.65M shares), Assenagon Asset Management S.A. (673K shares), Pacer Advisors, Inc. (602K shares), Impax Asset Management Group plc (540K shares), Bank of New York Mellon Corp (386K shares), PRINCIPAL FINANCIAL GROUP INC (267K shares), RICE HALL JAMES & ASSOCIATES, LLC (258K shares), VICTORY CAPITAL MANAGEMENT INC (208K shares), Jefferies Financial Group Inc. (174K shares), and Bridge City Capital, LLC (172K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.